Marc Espié

Generators and the Template Method Pattern. A Paradigm for Combinatorial Experimentation

Marc Espié, 2000 .

Molecular apocrine breast cancers are aggressive estrogen receptor negative tumors overexpressing either HER2 or GCDFP15

Raphaël Porcher, Marc Espié, Philippe Bertheau, 2013, Breast Cancer Research.

p53 in breast cancer subtypes and new insights into response to chemotherapy.

Raphaël Porcher, Marc Espié, Philippe Bertheau, 2013, Breast.

TP53 Status and Response to Chemotherapy in Breast Cancer

Jacqueline Lehmann, Marc Espié, Philippe Bertheau, 2008, Pathobiology.

Diffusion-weighted MRI in pretreatment prediction of response to neoadjuvant chemotherapy in patients with breast cancer

Isabelle Thomassin, Marc Espié, Eric de Kerviler, 2013, European Radiology.

18F-FDG PET/CT for the Early Evaluation of Response to Neoadjuvant Treatment in Triple-Negative Breast Cancer: Influence of the Chemotherapy Regimen

Matthieu Resche-Rigon, Marc Espié, Pascal Merlet, 2016, The Journal of Nuclear Medicine.

Early monitoring of response to neoadjuvant chemotherapy in breast cancer with 18F-FDG PET/CT: defining a clinical aim

Marc Espié, Domenico Rubello, D. Groheux, 2011, European Journal of Nuclear Medicine and Molecular Imaging.